Literature DB >> 7723571

p53 protein overexpression and chemosensitivity in breast cancer.

A Makris, T J Powles, M Dowsett, C Allred.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723571     DOI: 10.1016/s0140-6736(95)91014-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.

Authors:  G Wani; I Noyes; G E Milo; S M D'Ambrosio
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

2.  Sensitive and reliable PCR and sequencing used to detect p53 point mutations in fine needle aspirates of the breast.

Authors:  G P Howes; J Stephenson; S Humphreys
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 3.  P53, apoptosis, and breast cancer.

Authors:  D M Barnes; R S Camplejohn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

4.  p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

Authors:  James G Jackson; Vinod Pant; Qin Li; Leslie L Chang; Alfonso Quintás-Cardama; Daniel Garza; Omid Tavana; Peirong Yang; Taghi Manshouri; Yi Li; Adel K El-Naggar; Guillermina Lozano
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

5.  Drug resistance in ovarian cancer - the role of p53.

Authors:  R Petty; A Evans; I Duncan; C Kurbacher; I Cree
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Authors:  E Niskanen; C Blomqvist; K Franssila; P Hietanen; V M Wasenius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy.

Authors:  Robin M Hallett; Cheng Huang; Ali Motazedian; Stefanie Auf der Mauer; Gregory R Pond; John A Hassell; Robert E Nordon; Jonathan S Draper
Journal:  Oncotarget       Date:  2015-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.